You are now leaving the Amgen Population Health website. Please click Proceed to leave site or Cancel to remain on amgenpopulationhealth.com.

Proceed Cancel
Please check the CAPTCHA box.

Value-based Partnerships Vary in Scope and Size and Reflect a Joint Commitment to Move Health Care Forward

At Amgen, we partner with a variety of stakeholders across health care systems. By engaging with various stakeholders to help identify mutually beneficial opportunities, we aim to reduce costs, improve care, and enhance patient experiences worldwide.

As of 2017, we are currently involved in more than 75 distinct partnerships around the globe.

See examples of value-based partnerships with Amgen

Core Components of Successful
Value-based Partnerships

Address Clinical/Scientific Gap

Value-based partnerships must provide opportunities to advance patient care.

Examples:

  • Increasing disease awareness in a therapeutic area
  • Identifying appropriate patients in a therapeutic area
MUTUAL BENEFIT

Value-based partnerships should be beneficial for all engaged.

  • The goals of both parties should be clearly defined early in the process
  • Success metrics should be defined to indicate the success of the partnership

Example:

  • Co-development of resources that can be used by both partners to increase awareness to support improvement in disease management
MUTUAL CONTRIBUTION

All entities engaged in the value-based partnership invest resources in furthering the partnership. The value of contribution may vary depending on the tactics, output, and structure of the collaboration. Contributions from both parties should be equally beneficial to the partnership.

Example:

  • Contributions may include FTE time, data analytics, funding, and other output necessary for the project
JOINT DECISION-MAKING

Both parties participate in the development and execution of the collaboration.

Examples:

  • Joint Steering Committee
  • Co-development of algorithm, device, or application
  • Joint ownership of materials/output

Health Care Stakeholders for Value-based Partnerships May Include

Payers
  • CMS
  • Commercial health plans
  • Employers
  • Private HMOs
Patients
  • Patient associations
Research Institutions
  • Universities
  • Research trust/foundations
Technology Companies
  • Software/system providers
  • Hardware/device makers
Care Providers
  • Hospitals
  • Private clinics/networks
  • HCP organizations
  • Health care systems
  • ACOs
  • Integrated delivery systems
ACOs = accountable care organizations; CMS = Centers for Medicare & Medicaid Services; HCP = health care provider; HMOs = health maintenance organizations.

New Challenges Bring Novel Opportunities for Partnerships

We partner with like-minded entities in the health care system to jointly pursue opportunities to improve the efficiency, cost and quality of care, and the overall patient experience.

Concerted collaborative efforts can create new approaches to patient care that combine therapeutics, services, technology, and analytics into more holistic solutions leading to better patient outcomes, more satisfied providers, and a more financially sound medical ecosystem.

We envision multiyear project collaborations, such as

  • Evaluating the characteristics of specific populations
  • Testing innovative disease solutions
  • Exploring alternative reimbursement

We truly believe it will take the entire health care village to address the challenges and the opportunities to make life better for patients.

Our key partnership principles include mutually beneficial project aims, joint decision-making, co-investment of time and resources, and a commitment to act on generated insights.